Related Experiment Video

Updated: May 28, 2025

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach

Published on: June 11, 2017

11.2K

A Pediatric Research Imperative: Addressing Neonates in Drug Development Through Understanding Neonatal Clinical

An N Massaro1, Elimika Pfuma Fletcher2, Rajanikanth Madabushi2

  • 1Office of Pediatric Therapeutics, Office of the Chief Medical Officer, Office of the Commissioner, US FDA (DG, ANM), Silver Spring, MD.

The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|February 12, 2025
PubMed

Insights

Developing new medicines for newborns is crucial but challenging. This review covers regulatory, clinical, and ethical factors impacting neonatal drug development and suggests future research directions.

Area of Science:

  • Neonatal pharmacology
  • Pediatric drug development
  • Health care policy

Background:

  • Drug development for neonates is a significant unmet medical need.
  • Existing incentives have improved pediatric drug development but neonatal therapeutics face distinct hurdles.
  • Neonates represent a vulnerable population requiring specialized approaches to medication development.

Purpose of the Study:

  • To review the regulatory history, clinical, pharmacological, and ethical considerations in neonatal drug development.
  • To identify research priorities and future directions for advancing safe and effective neonatal medicines.

Main Methods:

  • Literature review of regulatory history.
  • Analysis of clinical, pharmacological, and ethical factors.
  • Discussion of research priorities and future directions.

Main Results:

  • Neonatal drug development is complex, influenced by unique physiological and ethical factors.
  • Regulatory frameworks and clinical trial designs require specific adaptations for neonates.
  • Ethical considerations are paramount in research involving this vulnerable population.

Conclusions:

  • Addressing the unmet need for neonatal therapeutics requires a multi-faceted approach.
  • Future research should focus on innovative methodologies and collaborative efforts to ensure safe and effective medications for neonates.
  • Overcoming challenges in neonatal drug development is essential for improving infant health outcomes.

Keywords:
drug developmentneonatepharmacologypreterm infant

More Related Videos

A Neonatal Rodent Model of Retroorbital Vein Injection04:39

A Neonatal Rodent Model of Retroorbital Vein Injection

Published on: February 23, 2024

5.4K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

85.8K

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
255
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
939
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K